(Press-News.org) When you think of hip replacement surgery, you generally envision an older adult with painful osteoarthritis. But the procedure is also used for younger patients with juvenile idiopathic arthritis (JIA) whose joints have been severely damaged by the disease.
A new study by Hospital for Special Surgery (HSS) researchers finds that total hip replacement (THR) is an excellent option for patients under age 35 when conservative treatments fail to provide relief.
The study, presented at the American College of Rheumatology annual meeting on November 16, found that hip replacement lasted at least 10 years in 85 percent of JIA patients. Twenty years out, 50 percent of the patients needed a revision surgery, or second hip replacement.
Juvenile idiopathic arthritis is a common rheumatologic disease in children that often persists into adulthood. It frequently affects the hip joint, and total hip replacement is the standard treatment to relieve pain and restore mobility when nonsurgical treatments no longer help.
"The surgery in this patient population, although performed by only a small number of specialized orthopedic surgeons nationwide, is life-changing for JIA patients," said Mark P. Figgie, M.D., senior author of the study and chief of the Surgical Arthritis Service at HSS. "Joint replacement can free patients from a life of unrelenting pain. It can enable those in a wheel chair to walk again. Patients can go back to school or work and get their lives back."
This study, titled, "Implant Survival and Patient-Reported Outcomes after Total Hip Arthroplasty in Young Patients with JIA," evaluated the longevity of implants in JIA patients ages 35 or younger who underwent hip replacement at Hospital for Special Surgery.
"This study followed one of the largest cohorts of patients with JIA to see how they fared 10 years and 20 years after total hip replacement," said Ishaan Swarup, M.D., an orthopedic surgery resident at HSS. "It is also one of the few studies to look at patient-reported measures, such as pain and the ability to perform activities of daily living."
Patient characteristics and implant data were collected by a retrospective chart review and follow-up surveys were conducted. Kaplan-Meier survival analysis was performed to evaluate how long the implant lasted, and the hip disability and osteoarthritis outcome score (HOOS) was used to describe patient-reported outcomes.
Data were collected for 56 patients. Forty-one patients had undergone bilateral hip replacement, while 15 individuals had only one side replaced, for a total of 97 hip replacement surgeries. The mean time for follow-up was 12 years. The 10-year and 20-year implant survival was 85 percent and 50 percent, respectively.
The researchers found that hip replacement in patients who were 25 or older lasted longer compared to THR in younger patients. There were no other significant differences in implant longevity based on gender or the use of custom versus standard implants.
Male patients reported better outcomes with respect to activities of daily living, and patients who had received custom hip implants did worse in their reporting of pain and the ability to perform daily activities.
"We were not surprised that the patients who received custom implants had lower scores, since the very fact that they needed a custom implant meant they had more severe joint deformities and more severe disease," Dr. Figgie explained.
"We concluded that overall, hip replacement is an excellent treatment option for young JIA patients with reasonable long-term implant survival and favorable patient-reported outcomes after surgery," Dr. Swarup said.
Although a good treatment, Dr. Figgie noted that the longevity of the implants needs to be improved, especially since the patients are so young. "The next step will be to evaluate which factors affect how long the implants last and work on improving implant design and durability," he said.
INFORMATION:
Other authors involved in the study include Ella Christoph; Lisa A. Mandl, MD; Susan M. Goodman, MD. All from Hospital for Special Surgery.
About Hospital for Special Surgery
Founded in 1863, Hospital for Special Surgery (HSS) is a world leader in orthopedics, rheumatology and rehabilitation. HSS is nationally ranked No. 1 in orthopedics, No. 3 in rheumatology and No. 7 in geriatrics by U.S.News & World Report (2014-15), and is the first hospital in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center three consecutive times. HSS has one of the lowest infection rates in the country. HSS is a member of the New York-Presbyterian Healthcare System and an affiliate of Weill Cornell Medical College and as such all Hospital for Special Surgery medical staff are faculty of Weill Cornell. The hospital's research division is internationally recognized as a leader in the investigation of musculoskeletal and autoimmune diseases. Hospital for Special Surgery is located in New York City and online at http://www.hss.edu.
Physicists have engineered a spiral laser beam and used it to create a whirlpool of hybrid light-matter particles called polaritons.
"Creating circulating currents of polaritons - vortices - and controlling them has been a long-standing challenge," said leader of the team, theoretician Dr Elena Ostrovskaya, from the Research School of Physics and Engineering at The Australian National University (ANU).
"We can now create a circulating flow of these hybrid particles and sustain it for hours."
Polaritons are hybrid particles that have properties of both matter and light. ...
CHICAGO and BOSTON - Nov. 16, 2014 - The Harvard Clinical Research Institute (HCRI) announced today results of the DAPT Study, a major international study that investigated the duration of dual antiplatelet therapy (DAPT, the combination of aspirin and a thienopyridine/antiplatelet medication to reduce the risk of blood clots) following coronary stent implantation. The continuation of dual antiplatelet therapy beyond one year resulted in significant benefits compared with aspirin alone, including reducing the rare but serious problem of stent thrombosis and preventing heart ...
Leading coral reef scientists in Australia and the USA say there needs to be a new approach to protecting the future of marine ecosystems, with a shift away from the current focus on extinction threat.
"Extinction is the final endpoint, but coral reefs are in deep trouble long before we get to that point. We need to take action much earlier," says Professor David Bellwood from the ARC Centre of Excellence for Coral Reef Studies (Coral CoE) at James Cook University.
"The goal should be to maintain reefs that can support corals, fish and humans" Professor Bellwood says.
In ...
VIDEO:
The neurons in this video contain a dye that fluoresces when it encounters calcium ions. When the neuron is excited, calcium floods into the cell and the neuron fluoresces. The...
Click here for more information.
Synapse, the name for the signal-receiving site on a neuron, comes from the Greek word for contact. Neuroscientists used to maintain that neurons form one-to-one relationship to contact one another. Yet more researchers are finding evidence that shows how neurons ...
VIDEO:
The movement of bone marrow B cells was limited in the absence of VCAM-1, as shown in this time-lapse video. B cells (green) were tracked before (left) and after (right)...
Click here for more information.
Newly formed B cells take the easy way out when it comes to exiting the bone marrow, according to a study published in The Journal of Experimental Medicine.
For infection-fighting T and B cells to defend the body, they must first leave their birthplace--the thymus for ...
This news release is available in German.
Infections due to the sexually transmitted bacterium Chlamydia trachomatis often remain unnoticed. The pathogen is not only a common cause of female infertility; it is also suspected of increasing the risk of abdominal cancer. A research team at the Max Planck Institute for Infection Biology in Berlin has now observed the breakdown of an important endogenous protective factor in the course of chlamydial infection. By activating the destruction of p53 protein, the bacterium blocks a key protective mechanism of infected cells, ...
Doctors tell us that the frenzied pace of the modern 24-hour lifestyle -- in which we struggle to juggle work commitments with the demands of family and daily life -- is damaging to our health. But while life in the slow lane may be better, will it be any longer? It will if you're a reptile.
A new study by Tel Aviv University researchers finds that reduced reproductive rates and a plant-rich diet increases the lifespan of reptiles. The research, published in the journal Global Ecology and Biogeography, was led by Prof. Shai Meiri, Dr. Inon Scharf, and doctoral student ...
If you want to see into the future, you have to understand the past. An international consortium of researchers under the auspices of the University of Bonn has drilled deposits on the bed of Lake Van (Eastern Turkey) which provide unique insights into the last 600,000 years. The samples reveal that the climate has done its fair share of mischief-making in the past. Furthermore, there have been numerous earthquakes and volcanic eruptions. The results of the drilling project also provide a basis for assessing the risk of how dangerous natural hazards are for today's population. ...
WASHINGTON, D.C. - Two or more serious hits to the head within days of each other can interfere with the brain's ability to use sugar - its primary energy source - to repair cells damaged by the injuries, new research suggests.
The brain's ability to use energy is critical after an injury. In animal studies, Ohio State University scientists have shown that brain cells ramp up their energy use six days after a concussion to recover from the damage. If a second injury occurs before that surge of energy use starts, the brain loses its best chance to recover.
In mice, ...
Mikhail Kosiborod, M.D., of Saint Luke's Mid America Heart Institute, Kansas City, and colleagues evaluated the efficacy and safety of the drug zirconium cyclosilicate in patients with hyperkalemia (higher than normal potassium levels). The study appears in JAMA and is being released to coincide with its presentation at the American Heart Association's Scientific Sessions 2014.
Hyperkalemia is a common electrolyte disorder which can cause potentially life-threatening cardiac arrhythmias and is associated with chronic kidney disease, heart failure, and diabetes mellitus. ...
